Publications by authors named "Jose Joaquin Portu"
Knowledge about COVID-19 and vaccine acceptability among priority groups defined for vaccination: A cross-sectional study in Araba/Alava, Spain, before the vaccination against SARS-CoV-2.
Naiara Parraza-Diez Cristina Bermudez-Ampudia Raquel Cobos-Campos Ines Garmendia Estibalitz Orruño Jose Joaquín Portu
Vaccine X
August 2022
Article Synopsis
- The study analyzes the willingness and knowledge about COVID-19 vaccines among patients and healthcare workers (HCWs) in Álava, Spain, highlighting the importance of understanding attitudes to improve vaccination strategies.
- A survey revealed that while about 90% of patients and 80% of HCWs were willing to get vaccinated, there was a notable hesitancy among HCWs (3-12%) due to concerns over vaccine effectiveness.
- HCWs demonstrated better knowledge and higher risk perception of COVID-19 compared to patients, indicating a need for improved communication about vaccine information for the general public.
Background: Following the introduction of direct-acting antiviral therapy in 2013, WHO launched the first Global Health Sector Strategy on Viral Hepatitis. We describe a hepatitis C virus (HCV) cascade of care in people with HIV (PWH) across Europe in terms of reaching the WHO elimination targets of diagnosing 90% and treating 80% of HCV-infected individuals.
Methods: HIV/HCV-coinfected participants in the EuroSIDA cohort under prospective follow-up at October 1, 2019, were described using a nine-stage cascade of care.
Article Synopsis
- The study analyzed changes in comorbidities and risk factors among HIV-positive individuals in Europe by comparing cohorts from 2006 and 2014.
- Results showed that the 2014 cohort had a higher median age and increased prevalence of hypertension, diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD) compared to 2006.
- Although individuals in 2014 had higher unadjusted odds for CKD and CVD, these associations became non-significant after adjusting for age and other factors, highlighting the need for integrated treatment strategies for aging HIV populations.